NCT04152018 2025-05-28Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.PfizerPhase 1 Terminated85 enrolled
NCT03860272 2025-02-06Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled